German Pharma Company Building $65 Million R&D Center in Connecticut
11/22/2011
The center will not add many permanent jobs, according to James Baxter, Boehringer's U.S. senior vice president for development. However, he noted the company's 25 employees R&D facility will remain in Ridgefield, as will other positions (about 100) dependent upon the work performed at the facility.
Based in Ridgefield, CT, Boehringer Ingelheim Pharmaceuticals is the largest U.S. subsidiary of Boehringer Ingelheim Corporation. It also is a member of the Boehringer Ingelheim group of companies (headquartered in Ingelheim, Germany), which operates globally with 145 affiliates and more than 42,000 employees.
Project Announcements
Amgen Expands New Albany, Ohio, Manufacturing Operations
04/28/2025
United Kingdom-Based Balmoral Tanks Plans Mentor, Ohio, Operations
04/28/2025
E & E Hardwoods Expands Bell County, Kentucky, Saw Mill Operations
04/27/2025
Aegis Sortation Expands Louisville, Kentucky, Operations
04/26/2025
Process Machinery Expands Shelby County, Kentucky, Production Operations
04/26/2025
HL Mechatronics Expands Williams Township, Michigan, Operations
04/26/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
The Location Economics of Advanced Nuclear
Q1 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Forging Solid Foundations
Q1 2025